Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionMadison Asset Management, LLC
Latest Disclosed Ownership3,712 shares
Latest Disclosed Value $ 225,133
Madison Asset Management, LLC ownership in BRM / Bristol-Myers Squibb Company

On May 7, 2026 - Madison Asset Management, LLC filed a 13F-HR form disclosing ownership of 3,712 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $194,583 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 3,712 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $176,060 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Bristol-Myers Squibb COM 110122108 3,712 0 0.00 225 12.50 0.0028
2026-02-04 2025-12-31 13F Bristol-Myers Squibb COM 110122108 3,712 3,712 200 0.0023
2025-08-11 2025-06-30 13F Bristol-Myers Squibb COM 110122108 0 -3,768 -100.00 0 -100.00
2025-05-06 2025-03-31 13F Bristol-Myers Squibb COM 110122108 3,768 0 0.00 230 7.51 0.0026
2025-02-10 2024-12-31 13F Bristol-Myers Squibb COM 110122108 3,768 -300 -7.37 213 1.43 0.0024
2024-11-12 2024-09-30 13F Bristol-Myers Squibb COM 110122108 4,068 -904 -18.18 210 1.94 0.0024
2024-08-09 2024-06-30 13F Bristol-Myers Squibb COM 110122108 4,972 -428,994 -98.85 206 -99.12 0.0026
2024-05-09 2024-03-31 13F Bristol-Myers Squibb COM 110122108 433,966 127,731 41.71 23,534 49.78 0.2895
2024-02-12 2023-12-31 13F Bristol-Myers Squibb COM 110122108 306,235 -58,824 -16.11 15,713 -25.84 0.2129
2023-11-13 2023-09-30 13F Bristol-Myers Squibb COM 110122108 365,059 -172,684 -32.11 21,188 -38.39 0.3110
2023-08-01 2023-06-30 13F Bristol-Myers Squibb COM 110122108 537,743 -27,597 -4.88 34,389 -12.24 0.5017
2023-04-26 2023-03-31 13F Bristol-Myers Squibb COM 110122108 565,340 -21,554 -3.67 39,184 93,192.86 0.5951
2023-02-08 2022-12-31 13F Bristol-Myers Squibb COM 110122108 586,894 -139,040 -19.15 42 -99.92 0.6625
2022-11-10 2022-09-30 13F Bristol-Myers Squibb COM 110122108 725,934 -152,360 -17.35 51,607 -23.69 0.8700
2022-08-09 2022-06-30 13F Bristol-Myers Squibb COM 110122108 878,294 65,284 8.03 67,629 13.90 1.0556
2022-05-12 2022-03-31 13F Bristol-Myers Squibb COM 110122108 813,010 -2,532 -0.31 59,374 16.77 0.8494
2022-02-15 2021-12-31 13F Bristol-Myers Squibb COM 110122108 815,542 -34,568 -4.07 50,849 1.09 0.6668
2021-11-12 2021-09-30 13F Bristol-Myers Squibb COM 110122108 850,110 153,237 21.99 50,301 8.02 0.6922
2021-08-09 2021-06-30 13F Bristol-Myers Squibb COM 110122108 696,873 -20,296 -2.83 46,565 2.85 0.6282
2021-05-11 2021-03-31 13F Bristol-Myers Squibb COM 110122108 717,169 -21,502 -2.91 45,275 -1.19 0.6315
2021-02-12 2020-12-31 13F Bristol-Myers Squibb COM 110122108 738,671 7,227 0.99 45,820 3.90 0.6734
2020-11-12 2020-09-30 13F Bristol-Myers Squibb COM 110122108 731,444 -4,971 -0.68 44,099 1.84 0.7368
2020-08-13 2020-06-30 13F Bristol-Myers Squibb COM 110122108 736,415 -6,948 -0.93 43,301 4.50 0.7595
2020-05-12 2020-03-31 13F Bristol-Myers Squibb COM 110122108 743,363 130,791 21.35 41,435 5.38 0.8511
2020-02-12 2019-12-31 13F Bristol-Myers Squibb COM 110122108 612,572 612,572 39,321 0.6038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.